Du, Xiaoping
- University of Illinois at Chicago · Pharmacology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #9,659
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$1M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#9,659
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Du, Xiaoping as a PI. Multi-PI records show the full award amount for context.
- 5R35HL150797-04R35Contact PIMechanisms of integrin signaling and a new anti-platelet/anti-inflammatory approachUniversity of Illinois at Chicago · Pharmacology (NIH department code)$959.4Kaward amount
- 3R35HL150797-04S1R35Contact PIMechanisms of integrin signaling and a new anti-platelet/anti-inflammatory approachUniversity of Illinois at Chicago · Pharmacology (NIH department code)$80.2Kaward amount
Award organization
Organizations that administered FY2023 awards listing Du, Xiaoping as a PI.
FY2023 award administered by University of Illinois at Chicago (IL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardUniversity of Illinois at Chicago
- 2006$500K Cumulative Funding
- 2006Entered Top 50% NationallyRanked #7801
- 2007$1M Cumulative Funding
- 2008$2M Cumulative Funding
- 2011$5M Cumulative Funding
- 2018$10M Cumulative Funding
- 2020Entered Top 25% NationallyRanked #3151